Gene expression profiling in drug discovery and development
- PMID: 19629863
Gene expression profiling in drug discovery and development
Abstract
Recent advances in technology, especially the merger between molecular biology, automation technology and computer science, are rapidly changing the manner in which pharmaceutical companies will discover new drug targets and develop new therapeutic drugs. One example of such a merger between different disciplines has been the development of technology platforms, such as cDNA microarrays and oligonucleotide arrays, allowing the generation of comprehensive gene expression profiles in a previously insurmountable throughput. Hereby, the major limitation is currently shifting from the efficient generation of biological information to the extraction of biological knowledge. However, given the foreseeable developments in data mining technologies and diverse computational biology tools, it can be anticipated that this information will foster the effectiveness to develop new and hopefully better drugs.
Similar articles
-
Where are we in genomics?J Physiol Pharmacol. 2005 Jun;56 Suppl 3:37-70. J Physiol Pharmacol. 2005. PMID: 16077195 Review.
-
Gene expression arrays in cancer research: methods and applications.Crit Rev Oncol Hematol. 2005 May;54(2):95-105. doi: 10.1016/j.critrevonc.2004.12.006. Crit Rev Oncol Hematol. 2005. PMID: 15843092 Review.
-
Gene expression quantitation technology summary.Methods Mol Biol. 2004;258:7-12. doi: 10.1385/1-59259-751-3:7. Methods Mol Biol. 2004. PMID: 14970454 Review.
-
Integrating microarrays into disease-gene identification strategies.Expert Rev Mol Diagn. 2003 May;3(3):375-85. doi: 10.1586/14737159.3.3.375. Expert Rev Mol Diagn. 2003. PMID: 12779011 Review.
-
Expression and microarrays.Methods Mol Biol. 2008;453:245-55. doi: 10.1007/978-1-60327-429-6_12. Methods Mol Biol. 2008. PMID: 18712307